2-Step Gene Sequencing Shows Who May Respond to Cancer Immunotherapy

Scientists used a process known as whole exome sequencing to examine 20,000 genes for a clearer picture of who may benefit from targeted cancer drugs known as immune checkpoint inhibitors.

Related Keywords

New York ,United States ,American ,Marcin Imieli ,Nature Communications ,York Genome Center ,American Cancer Society ,New York Genome Center ,New York City ,